New

Global ETF Survey 2026 Available: How 620 Professionals Select ETFs. Access the Report →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

Access Is Easy. Choosing the Right ETF Is Not

With 1,790 launches through July 2026, finding an ETF is easy and choosing one is not. 46% of share classes hold under $50 million, and nearly 7 in 10 allocators are reassessing their holdings, with portfolio fit the top criterion. See how 620 professionals select ETFs.

Trackinsight Global ETF Survey 2026
›ETF Issuers›VanEck›CIB0
CIB0

Vaneck Bionic Engineering Ucits ETF

The CIB0 Exchange Traded Fund (ETF) is provided by VanEck. It is built to track an index: MVIS Global Bionic Healthcare ESG Index. The CIB0 ETF provides physical exposure, so by buying it you actually own parts of all the 25 underlying holdings. The dividend policy is capitalization.

Advertisement

Advertisement

€17.10
+€0.19 (+1.12%) yesterday
6:00 AM 10/16/26 Closed
1D price range
€17.10€17.10
52W price range
€14.44€18.75
YTD Perf.
-7.51%
YTD Flows
Annualized volatility
Fund AuM
€12M
Share class AuM
€12M
TTM Yield
-
Tracking Error
Tracking Difference
ISIN
IE0005TF96I9
TER
0.55%
Inception date
12/2/2022
Issuer
Replication method
Dividend policy
Compare similar ETFs
API
PerformanceDec 31, 2025 - Oct 15, 2026
-20%-15%-10%-5%0%JANMARMAYJULSEP
Flows
Join for free to unlock
Data as of 08/31/26
Healthcare
100.00%
Latest CIB0 news

No content available for this fund

FAQ about CIB0

CIB0 is a Passive ETF. This ETF provides exposure to Equities.
CIB0 tracks the MVIS Global Bionic Healthcare ESG Index (NTR) - USD, through a full replication replication method.
CIB0 carries a total expense ratio (TER) of 0.55%, indicating the annual cost for holding the fund.
CIB0 was introduced to the market on December 2, 2022. It trades on Romania, among other exchanges
Vaneck Bionic Engineering Ucits ETF, CIB0, is provided by VanEck. Learn more about VanEck here.
CIB0 oversees €12M in assets as of October 15, 2026.
CIB0 follows a capitalizing, meaning it reinvests income within the fund.
As of August 31, 2026, CIB0 has significant geographic allocations in USA, Ireland and Switzerland.
As of August 31, 2026, CIB0 focuses largely on Healthcare.
As of August 31, 2026, CIB0 holds 25 positions in its portfolio, with 80.14% of assets concentrated in its top 15 holdings.
As of August 31, 2026, CIB0 top three holdings include Medtronic Plc, Edwards Lifesciences Corp. and Stryker Corp..
The base currency of CIB0 is USD.
Data as of 08/31/26
Medtronic Plc
10.34%
Edwards Lifesciences Corp.
9.66%
Stryker Corp.
9.60%
Intuitive Surgical, Inc.
8.37%
DexCom, Inc.
7.75%
Sonova Holding AG
4.42%
Straumann Holding AG
4.06%
Zimmer Biomet Holdings, Inc.
3.99%
Glaukos Corp.
3.75%
Smith & Nephew plc
3.46%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight